What is the new dose of Wegovy approved by the FDA?

The FDA has approved a new, higher 7.2-milligram dose of Wegovy, which is a weekly injection.

How effective is the higher-dose Wegovy for weight loss?

In a study, the higher 7.2mg dose of Wegovy helped participants lose about 19% of their body weight over nearly 17 months.

What are the side effects of the higher Wegovy dose?

Side effects such as nausea, vomiting, and constipation were reported in over 70% of those taking the higher 7.2mg dose of Wegovy.

Home / Health / FDA OKs Stronger Wegovy for More Weight Loss

FDA OKs Stronger Wegovy for More Weight Loss

20 Mar

•

Summary

New 7.2mg Wegovy dose approved by FDA for greater weight loss.
Higher dose helped study participants lose nearly 19% body weight.
Common side effects like nausea increased with higher Wegovy dose.

FDA OKs Stronger Wegovy for More Weight Loss

Federal regulators have approved a new, higher-dose version of the obesity drug Wegovy. The U.S. Food and Drug Administration (FDA) has cleared a 7.2-milligram dose of semaglutide, the active ingredient in Wegovy, for use. Previously, the highest approved dose was 2.4 milligrams. This new dosage received an accelerated review.

The higher-dose Wegovy, known as Wegovy HD, was shown in a study to help participants lose about 19% of their body weight over nearly 17 months. This is compared to approximately 16% weight loss achieved with the lower 2.4-milligram dose. The development of the higher dose was prompted by observations that some individuals do not reach their therapeutic weight loss goals with the existing highest dose.